NCT00284856View on ClinicalTrials.gov

Montelukast Asthmatic Smoker Study (0476-332)(COMPLETED)

PHASE3CompletedINTERVENTIONAL
Enrollment

1,640

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions
Asthma
Interventions
DRUG

montelukast sodium

montelukast 10 mg tablet once daily, 6 month treatment period

DRUG

Comparator: Placebo

fluticasone propionate 250 mcg Placebo (Pbo) twice daily, 6 month treatment period

DRUG

Comparator: fluticasone

fluticasone propionate 250 mcg twice daily, 6 month treatment period

DRUG

Comparator: Placebo

montelukast 10 mg Pbo tablet once daily, 6 month treatment period

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00284856 - Montelukast Asthmatic Smoker Study (0476-332)(COMPLETED) | Biotech Hunter | Biotech Hunter